Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study
出版年份 2021 全文链接
标题
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study
作者
关键词
-
出版物
Journal of Chemical Information and Modeling
Volume 61, Issue 11, Pages 5469-5483
出版商
American Chemical Society (ACS)
发表日期
2021-10-21
DOI
10.1021/acs.jcim.1c00524
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
- (2021) Hylemariam Mihiretie Mengist et al. Frontiers in Chemistry
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Peptide-like and small-molecule inhibitors against Covid-19
- (2020) Suyash Pant et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
- (2020) Rameez Jabeer Khan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
- (2020) Anuj Kumar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening
- (2020) Osmair Vital de Oliveira et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
- (2020) Abdo A. Elfiky JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
- (2020) Rakesh S. Joshi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
- (2020) Nisha Muralidharan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
- (2020) Ammar D. Elmezayen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
- (2020) Manoj Kumar Gupta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
- (2020) Sukanth Kumar Enmozhi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease
- (2020) Chinmayee Choudhury JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary
- (2020) Mohamed A. Hendaus JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- 15 drugs being tested to treat COVID-19 and how they would work
- (2020) Leah Shaffer NATURE MEDICINE
- Covid-19 — The Search for Effective Therapy
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
- (2020) José Antonio Encinar et al. Viruses-Basel
- A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
- (2020) Donald C. Hall et al. Travel Medicine and Infectious Disease
- Use of antiviral drugs to reduce COVID-19 transmission
- (2020) Oriol Mitjà et al. Lancet Global Health
- Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
- (2020) Sebastiano Bruno Solerte et al. ACTA DIABETOLOGICA
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- Is DPP4 inhibition a comrade or adversary in COVID-19 infection
- (2020) Rinkoo Dalan DIABETES RESEARCH AND CLINICAL PRACTICE
- Tackling SARS-CoV-2: proposed targets and repurposed drugs
- (2020) Siddhi Joshi et al. Future Medicinal Chemistry
- COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
- (2020) Yang Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
- (2020) K. G. Arun et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Drug targets for COVID-19 therapeutics: Ongoing global efforts
- (2020) Ambrish Saxena JOURNAL OF BIOSCIENCES
- Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies
- (2020) Sumit Kumar et al. Journal of Chemical Information and Modeling
- Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
- (2020) Son Tung Ngo et al. Journal of Chemical Information and Modeling
- SARS-CoV-2 Main Protease: A Molecular Dynamics Study
- (2020) Dimas Suárez et al. Journal of Chemical Information and Modeling
- Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease
- (2020) Anuj Gahlawat et al. Journal of Chemical Information and Modeling
- Systemic in Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server
- (2020) Chi Xu et al. Journal of Chemical Information and Modeling
- COVID-19: Drug Targets and Potential Treatments
- (2020) Carmen Gil et al. JOURNAL OF MEDICINAL CHEMISTRY
- p38 MAPK inhibition: A promising therapeutic approach for COVID-19
- (2020) Joseph M. Grimes et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19
- (2020) Rashi Jain et al. STRUCTURAL CHEMISTRY
- Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
- (2020) Zena Wehbe et al. Frontiers in Pharmacology
- COVID-19 Therapeutic Options Under Investigation
- (2020) Malak Kaddoura et al. Frontiers in Pharmacology
- 1735P SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models
- (2020) C.A. Stewart et al. ANNALS OF ONCOLOGY
- Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
- (2020) Arif Hussain et al. BIOMEDICINE & PHARMACOTHERAPY
- Efficacy of Remdesivir in COVID-19
- (2020) Erin K. McCreary et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast
- (2020) Muhammad Qutayba Almerie et al. MEDICAL HYPOTHESES
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro
- (2020) Valeria Cagno et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
- (2019) Yusen Zhou et al. Viruses-Basel
- Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor
- (2019) Xiufang Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
- (2018) Hari Krishna Ananthula et al. BMC Pharmacology & Toxicology
- 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7
- (2017) Sarfaraz Alam et al. Scientific Reports
- Pharmacologic therapy for acute pancreatitis
- (2014) Swetha Kambhampati WORLD JOURNAL OF GASTROENTEROLOGY
- Phase I–IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours
- (2013) Jean-Charles Soria et al. EUROPEAN JOURNAL OF CANCER
- QSAR Modeling: Where Have You Been? Where Are You Going To?
- (2013) Artem Cherkasov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prediction of antiprion activity of therapeutic agents with structure–activity models
- (2013) Katja Venko et al. MOLECULAR DIVERSITY
- High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors
- (2013) Karthikeyan Muthusamy et al. Interdisciplinary Sciences-Computational Life Sciences
- Mechanistic Characterization of GS-9190 (Tegobuvir), a Novel Nonnucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase
- (2011) I-hung Shih et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now